Alnylam Pharmaceuticals
ALNY
#539
Rank
โ‚ฌ37.90 B
Marketcap
286,91ย โ‚ฌ
Share price
0.25%
Change (1 day)
7.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company